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Background: This study aimed to assess the reliability, validity, and factor structure of the Patient Health
Questionnaire-9 (PHQ-9) and its two subscales (PHQ-2, PHQ-1) for screening major depression disorder
(MDD) in primary care elderly patients in Taiwan.
Method: A total of 634 participants aged 60 years were enrolled from the primary care settings. They
completed PHQ-9, and Short Form of Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-
SF). After that, they were interviewed by using Schedule for Clinical Assessments in Neuropsychiatry
(SCAN) and 17-item of Hamilton Rating Scale (HAMD-17).
Result: The PHQ-9 demonstrated acceptable internal consistency (a ¼ 0.77), test-retest reliability
(intraclass correlation coefﬁcient ¼ 0.79), and concurrent validity with HAMD-17 (r ¼ 0.66; p < 0.001).
Exploratory factor analysis yielded 2-factor structure consisted of non-somatic (13.3% variance) and
somatic (38.8% variance) dimensions. The correlations between PHQ-9 with Q-LES-Q-SF (whole and two
subscales) were moderate (r range 0.47 to 0.53, all ps < 0.001). Using SCAN as gold standard, the
optimal cutoff score of 6 for PHQ-9 demonstrated good sensitivity and speciﬁcity for detecting MDD
(1.00 and 0.85, respectively). The screening accuracy of the two items version was also acceptable (PHQ-2
score  2: sensitivity 0.93; speciﬁcity 0.90; PHQ-1 score  1: sensitivity 1.00; speciﬁcity 0.77).
Conclusion: The Chinese versions of the PHQ-9 and its two subscales (PHQ-2 and PHQ-1) are valid and
reliable to screen MDD in primary care elderly patients in Taiwan and could be proper alternatives to
Geriatric Depression Scale 15-item version.
Copyright © 2016, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Depression in old age has become a major public health issue.
Despite its high prevalence and association with impairment in
quality of life1, it is frequently under-diagnosed and under-
treated, particularly in non-mental health settings2. Early recog-
nition and treatment of depression in older populationwill lead to
improve daily functions and mortality3,4. Thus, an importantre that they have no conﬂicts
tment of Psychiatry, MacKay
strict, New Taipei City 25160,
tric Emergency & Critical Care Med
es/by-nc-nd/4.0/).strategy to enhance the detection of depression is the use of
screening tool.
There are a variety of screening instruments to measure the
severity of depression in the different settings, such as the Beck
Depression Inventory5, Centre for Epidemiologic Studies Depres-
sion Scale6, Geriatric Depression Scale 15-item version (GDS-15)7.
However, these tools have not become very popular in primary care
because of the sheer volume of questions listed, which can be quite
overwhelming to the patient and time-consuming to complete. A
widespread tendency is the use of short versions of scales,
simplifying the application of large scales for physicians. The Pa-
tient Health Questionnaire-9 (PHQ-9) is half the length of other
depression measures, and has been widely in use internationally,
including Chinese population8,9. The PHQ-9 surveys nine symp-
toms of the DSM-IV diagnostic criteria for major depressiveicine. Published by Elsevier Taiwan LLC. This is an open access article under the CC
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instrument that evaluate the severity of this disorder and at the
same time, establish the MDD diagnosis for the patient10. Mean-
while, the ultra-brief screening tools, PHQ-2 (i.e., the ﬁrst two items
of the PHQ-9) and PHQ-1 (single item, depressed mood), have been
used as initial screening tests for MDD with the potential to reduce
the burden of depression screening.
To our knowledge, PHQ-9 screening characteristics have not
been validated with the elderly in primary care in Taiwan. Our aim
was to investigate the psychometric properties of the PHQ-9 and its
two subscales, the PHQ-1 and PHQ-2, in identifying elderly patients
with MDD.
2. Method
2.1. Setting and sample
The original main study was a randomized controlled trial to
test the effectiveness of a collaborative care intervention for pa-
tients with MDD in primary care in Taipei, which was conducted
between January 2009 and March 2012. The pilot trial of the above
main study was to test its feasibility and develop appropriate in-
struments such as PHQ-99. The pilot trial was conducted from
September 2007 through December 2008 in six community-based
primary care clinics and hospital-based outpatient clinics of the
Department of Family Medicine in Taipei.
The institutional review board at the MacKay Memorial Hos-
pital approved all procedures (No. MMH-I-S-241). Eligible partic-
ipants in the pilot trial were primary care participants who aged
18, spoke or understood Mandarin/Fukien dialects, and were
absence of severe cognitive or hearing impairment. We chose
patients who aged 60 from the data of the pilot trial for sec-
ondary analysis.
2.2. Measurements
The PHQ-9 consists of nine items, each evaluating one of the
nine DSM-IV criteria of MDD in the past two weeks. Each of the
nine items was rated on a 4-point scale, ranging from 0 (not at all)
to 3 (nearly every day)dsumming up to a total PHQ-9 score, with
higher scores indicating increased likelihood for MDD. Consistent
with the process for translation of survey instrument outlined in
prior studies11, translation and back translation of the Chinese
version of the PHQ-9 were repeated until the translators thought
the Chinese version corresponded closely with the English version.
The Chinese version of the PHQ-9 has been validated for primary
care adults and adolescent students in Taiwan9,12.
The Schedule for Clinical Assessments in Neuropsychiatry
(SCAN) is a set of clinical instruments aiming to assess psychopa-
thology and behavior associatedwithmajor psychiatric disorders in
adults. The mood module of the SCAN was our criterion standard
measure for MDD13. There was good interrater reliability between a
research psychiatrist and the research nurses (generalized kappa of
0.88 for diagnosis of MDD according to DSM-IV standards) in the
current study.
Measurement of depression severity was performed with the
17-item of Hamilton Rating Scale for Depression (HAMD-17), a
widely used interview-based instrument to assess the severity of
MDD. Each question has between 3 and 5 possible responses that
increase in severity. The Chinese version of the HAMD-17 has been
demonstrated to have good interrater reliability and internal
reliability14.
The Short Form of Quality of Life Enjoyment and Satisfaction
Questionnaire (Q-LES-Q-SF) uses the 14 general activities of the
regular form (Q-LES-Q) as well as two global items with higherscores indicating better enjoyment and satisfaction with life. The
scoring of Q-LES-Q-SF involves summing only the ﬁrst 14 items to
yield a total score. We used Chinese version of Q-LES-Q-SF as the
measure for quality of life. The internal consistency of the Q-LES-Q-
SF was 0.8715.2.3. Study procedures
After the participants agreed to participate and signed the
informed consent, they were asked to complete the PHQ-9 and the
Q-LES-Q-SF. Then, the trained research staff whowas blinded to the
results from the PHQ-9 interviewed them using the depression
module of the SCAN and the HAMD-17. A subsample of participants
was invited to re-take the PHQ-9 again within two weeks. All in-
struments were given on the same day in the context of their clinic
appointment.2.4. Statistical analyses
Data were analyzed with SPSS 21.0 software (IBM, Armonk, NY,
USA). MDD and non-MDD patients were compared on de-
mographic characteristics and mean scores of each measure (t test,
chi-square, ﬁsher's exact test, and adjust p-values for multiple
comparisons with Bonferroni method). Inter-item reliability of the
PHQ-9 was established by calculating Cronbach's coefﬁcient a for
the nine-item scale. Test-retest reliability within two-week interval
was examined by using the intraclass correlation coefﬁcient (ICC).
The concurrent validity was examined by calculation of the Pear-
son's correlation coefﬁcient (r) between the PHQ-9 and the
appropriate instruments.
The exploratory factor analysis (EFA) was conducted with
principal component analysis and varimax rotation to evaluate the
construct validity. The conﬁrmatory factor analysis (CFA) was
performed with SPSS AMOS 18.0 software (IBM). The chi-square
(c2) test, degrees of freedom (df), goodness-of-ﬁt index (GFI),
adjusted GFI (AGFI), and the root of the mean square residual
(RMR) were applied to assess the ﬁt of the model. Criterion val-
idity tested the performance of PHQ-9 and its two subscales in
comparison to the criterion standard, using SCAN diagnosis.
Receiver-operating characteristic (ROC) curves were generated to
compare the ability of these screening instruments, namely, PHQ-
9, PHQ-2, and PHQ-1. Sensitivity, speciﬁcity, positive predictive
value (PPV) and negative predictive value (NPV) were calculated.
The optimal cutoff point for each instrument was determined by
ROC analysis with the highest sum of sensitivity and speciﬁcity. All
data analyses used two-tailed tests; p < 0.05 was considered sig-
niﬁcant differences.3. Results
3.1. Participant characteristics
A total of 799 patients were approached and 634 subjects
completed the assessments. Most of them were from community-
based primary care settings (89.7%, n ¼ 569), and the rest was
from hospital-based family physician clinics (10.3%, n ¼ 65). The
participants were predominant female (58.8%) and low education
levels. One-month prevalence rate of MDD was 2.2%. Characteris-
tics of the sample according to MDD status were showed in Table 1.
The mean score of PHQ-9 for full sample were 2.6 (SD ¼ 3.7).
Compared with non-MDD individuals, those with MDD were more
signiﬁcantly likely to be female, the separated/divorced, and have
low socio-economic status (SES).
Table 1
Characteristics of the study population according to SCAN-diagnosed MDD status.
Characteristics Non-MDD (n ¼ 620) MDD (n ¼ 14) p value
N or mean % or SD N or mean % or SD
Gender 0.039*
Male 259 41.8 2 14.3
Female 361 58.2 12 85.7
Age (years) 71.5 7.1 71.4 7.1 0.989
Education years 0.437
6 379 62.3 11 78.6
7e12 155 25.5 3 21.4
13 74 12.2 0 0.0
Marriage 0.012*
Single 5 0.9 0 0.0
Married & live with a partner 373 70.5 3 30.0
Separated & divorced 15 2.8 2 20.0
Widowed 136 25.7 5 50.0
Occupation 0.055
Full-time 65 12.4 0 0.0
Part-time 10 1.9 0 0.0
Unemployed 33 6.3 3 30.0
Homemaker 90 17.1 0 0.0
Retired 328 62.4 7 70.0
Socioeconomic status 0.024*
Professional & semi-professional 20 3.8 1 10.0
Non-manuel skilled worker 198 37.9 1 10.0
Manuel skilled worker 181 34.6 2 20.0
Semi-skilled & non-skilled labor 124 23.7 6 60.0
Religion 0.061
Christianity & catholicism 54 10.3 1 10.0
Other & no religions 471 89.7 9 90.0
PHQ-9 score 2.3 3.2 13.1 4.5 <0.001*
HAMD-17 score 1.4 2.7 18.1 3.8 <0.001*
Q-LES-Q-SF score 48.0 5.7 38.5 3.0 <0.001*
*p Value < 0.05.
MDD: major depressive disorder.
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The Cronbach's a coefﬁcient was 0.77 showing an acceptable
internal consistency. To assess test-retest reliability, 82 of the 634
persons were asked to re-take the PHQ-9 within two weeks. An ICC
test-retest reliability of the total scores was 0.79 (95% CI, 0.67e0.86;
F ¼ 4.66, df ¼ 81, p < 0.001), suggesting little variability between
the two-week interval of administration.Figure 1. Scree plot of the PHQ-9.3.3. Construct validity: factor analysis
The Bartlett's test was statistically signiﬁcant (p < 0.001), and
the Kaiser-Meyer-Olkin value was 0.835. EFA and the scree plot
(Figure 1) indicated two factors. Factor 1 consisted of ﬁve items
related to “somatic problems” with eigenvalue of 3.49, accounting
for 38.8% variance. Factor 2, consisting of four items, was more
related to “non-somatic problems” with eigenvalue of 1.19, ac-
counting for 13.3% variance. All the factor-pattern coefﬁcients were
above 0.40, so each itemwas salient (Table 2). The 2-factor model ﬁt
better than 1-factor model, which was conﬁrmed by CFA. The re-
sults of CFA for 2-factor model revealed that c2 ¼ 131.06, df ¼ 26,
p < 0.001, GFI ¼ 0.96, AGFI ¼ 0.93, and RMR ¼ 0.02. All these values
were regarded as acceptable. The factor loadings for each of the
nine items ranged from 0.40 to 0.85, and all of the factor loadings
were signiﬁcant at p < 0.05.3.4. Concurrent validity of PHQ-9 assessed by HAMD-17 and Q-LES-
Q-SF
As shown in Table 3, the concurrent validity of the PHQ-9 versus
other instruments was examined. Correlations between the PHQ-9and the HAMD-17 were moderate; correlations between the PHQ-9
and the Q-LES-Q-SF (the whole scale and two subscales) were
moderate, but negative. These results conﬁrmed concurrent val-
idity of PHQ-9.
3.5. Criterion validity of PHQ-9, PHQ-2 and PHQ-1
The cutoff scores and validating parameters for the three scales
were presented in Table 4. Using SCAN diagnosis as the criterion
standard, the PHQ-9 score of 6 had the sensitivity of 100.0% and
Table 2
Construct validity of PHQ-9: individual item loadings for factor analysis (n ¼ 634).
Items Component
Somatic
dimension
Non-somatic
dimension
3 Trouble falling or staying asleep,
or sleeping too much
0.471
4 Feeling tired or having little energy 0.640
5 Poor appetite or overeating 0.673
7 Trouble concentrating on things 0.711
8 Moving or speaking so slowly,
or the opposite
0.660
1 Little interest or pleasure in doing things 0.520
2 Feeling down, depressed, or hopeless 0.666
6 Feeling bad about yourself 0.822
9 Thoughts that you would be better off dead 0.794
Extraction method: principal component analysis.
Rotation method: varimax with Kaiser normalization.
Table 3
Concurrent validity of the PHQ-9, with the HAMD-17, Q-LES-Q-SF, psychosocial
dimension, and physical dimension of the Q-LES-Q-SF for the whole sample.
Measures PHQ-9
Whole
scale
PHQ-9
Non-somatic
component
PHQ-9
Somatic
component
Q-LES-Q-SF total score 0.53** 0.47** 0.47**
Q-LES-Q-SF psychosocial dimension 0.47** 0.45** 0.40**
Q-LES-Q-SF physical dimension 0.48** 0.37** 0.46**
HAMD-17 0.66** 0.55** 0.60**
**p Value < 0.001.
HAMD-17: 17-item Hamilton Rating Scale for Depression; PHQ-9: Patient Health
Questionnaire-9; Q-LES-Q-SF: Short Form of the Quality of Life Enjoyment and
Satisfaction Questionnaire.
Table 4
Cutoff scores and validating parameters for major depression in Taiwanese elderly:
PHQ-9, PHQ-2, and PHQ-1 (n ¼ 634).
Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%)
PHQ-9
Score 5 100.0 80.8 10.5 100.0
Score ≥6 100.0 85.0 13.1 100.0
Score 7 92.9 88.5 15.5 99.8
Score 8 85.7 91.0 17.6 99.6
Score 9 78.6 93.7 22.0 99.5
Score 10 78.6 95.5 28.2 99.5
Score 11 71.4 97.1 35.7 99.3
Score 12 71.4 97.7 41.7 99.3
Score 13 57.1 97.9 38.1 99.0
PHQ-2
Score 1 100.0 75.5 8.4 100.0
Score ≥2 92.9 89.7 16.9 99.8
Score 3 50.0 94.5 17.1 98.8
PHQ-1
Score ≥1 100.0 77.3 9.0 100.0
Score 2 78.6 91.8 17.7 99.5
Score 3 35.7 96.8 20.0 98.5
NPV: negative predictive value; PHQ-9: Patient Health Questionnaire-9; PPV: pos-
itive predictive value.
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PHQ-9 was 0.97 (95% CI ¼ 0.94e0.99). The validating parameters
and the AUCs for the two subscales, PHQ-2 and PHQ-1, in detecting
MDD were also good.4. Discussion
This is the ﬁrst validation of the use of PHQ-9, PHQ-2, and PHQ-1
in primary care elderly patients in Taiwan. Our results reveal that
they are all reliable and valid measures for detecting MDD.Our study found that the PHQ-9 optimal cutoff of6, which was
lower than the recommended cutoff scores on the PHQ-9 for pre-
vious studies in adult patients (10) and adolescent students (15)
in Taiwan9,12. Another primary care study investigating elderly
patients in China showed an optimal cutoff of 9, but the study
design that recruitment of higher proportion of patients with
higher scores of PHQ-9 possibly led to a higher optimal cutoff8.
Nonetheless, the similar lower cutoff point of 5 for elderly pop-
ulation was also reported by a Korean study11. A plausible expla-
nation of the low cutoff point in our result was partly because of the
low mean score of our participants, being much lower than that
reported in the US elderly (mean score: 2.6 vs. 5.9)16. When
compared with the mean PHQ score of elderly participants with
MDD, that of Taiwanese was 13.1, lower than that of Koreans
(17.6)11. This highlights the importance of validating psychometric
measures in different cultural and age contexts. This should be
emphasized when relating to a speciﬁc cutoff score, regarding the
characteristics of the population and the settings.
The PHQ-9 is often as a ﬁrst-line screening instrument. The high
sensitivity (100%) of the cutoff point 6 is a required characteristic
of a screening tool in order not to miss cases. Nonetheless, the PPV
was low (13.1%), which could be attributed to the low prevalence
rate of MDD. Over half the participants who tested positive were
false-positives. In a depression screening programme, this could
lead to additional investigation in many non-depressed patients.
The clinician may consider performing a more comprehensive
interview following a positive screening test rather than prompt
treatment. Clinicians can choose a higher cutoff point to lower the
false-positive rate, yet should remember some depressed cases
would be under-recognized.
The one-month prevalence rate of MDD was low (2.2%) in our
study, with the ﬁgure being much lower than that reported in the
literature which validated the PHQ-9 in community and primary
care settings (varying from 5.8% to 12.0%)11,16. However, this was
similar to the low prevalence rate reported in an earlier national
survey of the community-living adults between 2003 and 2005 in
Taiwan, with 12-month and lifetime prevalence being 0.6% and
1.2%, respectively. The low prevalence of MDD in Taiwan might be
attributed to the methodological differences of sampling and
cultural stoicism17. The prevalence of MDD in our sample was
signiﬁcantly higher in female, the separated/divorced, and those
with lower SES. The association between MDD and these factors
was in keeping with previous research results in Taiwan17,18.
People who are divorced possibly feel isolated and lonely and are
less willing to communicate with other people, increasing the
likelihood of depression19. Risk factors associated with MDD may
assist clinicians to identify high-risk patients and target strategies
accordingly.
The EFA for the geriatric PHQ-9 yielded the 2-factor structure,
which was conﬁrmed by CFA. The 1-factor structure of the PHQ-9
has been reported in most studies with heterogeneous character-
istics of races, ages, and medical settings including Taiwanese
adults and adolescents9,12,20. Nonetheless, support for the 2-factors
of the PHQ-9 has also been found in racially diverse groups with
different kinds of settings and somatic conditions, including pri-
mary care adults21, pregnant women22, patients receiving palliative
care23, and a psychiatric sample24. These ﬁndings indicate that
sociocultural factors and age could affect the factor structure of the
PHQ-9 among Taiwanese individuals. A plausible explanation is
that the Taiwanese elderly are more likely to somatize their psy-
chological distress, especially for those with low education. Based
on the DSMeIV and DSM-5, which suggest that somatic symptoms
may be the primary presenting symptom for MDD among many
(ostensibly non-Western) cultures, we speculate that somatic
symptoms may be especially strongly related to elderly Taiwanese
Validation of the PHQ-9 in Elderly Patients in Taiwan 197withMDD. From this point of view, the PHQ-9 has some advantages
compared with GDS-15 because PHQ-9 has ﬁve somatic symptoms
relating to diagnostic criteria, which might be more sensitive to
screen depression than GDS-15. This hypothesis was partially
supported by that the somatic subscale accounted for 38.8% vari-
ance. The results suggest clinicians may ﬁnd it beneﬁcial to identify
depression symptoms and examine responses separately for these
two dimensions (somatic vs. non-somatic) in primary care elderly
patients.
Regarding concurrent validity, correlations between the PHQ-9
and the dimensions of Q-LES-Q-SF were negative signiﬁcantly.
The result was in line with previous studies15. The more depressed
patients reported lower enjoyment and satisfaction of quality of
life.
In our study, the PHQ-2 was more satisfactory than PHQ-1
regarding the test characteristics. For screening MDD in clinical
practice, we recommend that primary care staff may ask patients to
respond to the PHQ-2 initially with beneﬁt of time-saving brevity. If
the patients score 2, they should then complete the PHQ-9.
The strengths of this study included the validation of the three
depression screens, and avoiding interviewer bias. The validated
criterion standard instrument was administered by trained re-
searchers who were blinded to the results of the depression
screening tools. The study sample included large groups of patients
from community-based and hospital-based primary care clinics.
This study has several limitations. First, the study patients only
came from the northern Taiwan, so the results might differ some-
what in national settings. Second, the validity of the depression
instruments for persons with speciﬁc cognitive impairment was
not examined. Finally, medical comorbidities were not investi-
gated, which might be a confounding factor to subjective depres-
sion symptoms.5. Conclusion
The Chinese versions of the PHQ-9 and its two subscales are
valid and reliable to screen MDD in elderly primary care patients in
Taiwan. The PHQ-9 could be a proper alternative to the GDS-15.
They are useful means of screening late-life depression to pro-
mote primary care-based collaborative care.Reference
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